Melanocortin receptors, melanotropic peptides and penile erection

Current Topics in Medicinal Chemistry

Volumn 7, Issue 11, 2007, Pages 1111-1119

  King, Stephen H ^a,b   Mayorov, Alexander V ^a,b   Balse Srinivasan, Preeti ^a,b   Hruby, Victor J ^a,b   Vanderah, Todd W ^a,b   Wessells, Hunter ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b University of Arizona   (United States)

Author keywords

Erectogenic; Hindbrain melanocortin signaling; Melanotan II; Npgi neurons; Pt 141; Thiq

Indexed keywords

ACETYLNORLEUCYLCYCLO(ASPARTYLHIDSTIDYL DEXTRO PHENYLALANYLARGINYLTRYPTOPHANYLLYSYL)AMIDE; AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; AVM 127; BETA INTERMEDIN; BETA INTERMEDIN[11-22][11 (N ACETYLCYSTEINE) 14 [3 (2 NAPHTHYL) DEXTRO ALANINE] 18 CYSTEINE 22 ASPARTIC ACID AMIDE] 11,18 CYCLIC DISULFIDE; BREMELANOTIDE; CORTICOTROPIN; CYCLO(NORLEUCYLVALYL DEXTRO 2 NAPTHYLALANYLARGINYLTRYPTOPHANYLGLUTAMYL)AMIDE; GAMMA INTERMEDIN; HEPTAPEPTIDE; HORMONE RECEPTOR AFFECTING AGENT; HYDROTYROSYLVALYLMETHIONYLGLYCYLHISTIDYLPHENYLALANYLARGINYL DEXTRO TRYTOPHANYLASPARTYLARGINYLPHENYLALANYLGLYCYLHYDROXIDE; INTERMEDIN DERIVATIVE; LIGAND; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; MELANOCORTIN RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; MELANOCORTIN RECEPTOR ANTAGONIST; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; N ACETYLNORLEUCYLASPARTYLHISTIDYL DEXTRO PHENYLALANYLARGINYLTRYPTOPHYLLYSINE 2,7 CYCLIC AMIDE; N(G) NITROARGININE METHYL ESTER; OXYTOCIN RECEPTOR; PLACEBO; RECEPTOR SUBTYPE; SILDENAFIL; TADALAFIL; TETRAHYDROISOQUINOLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VARDENAFIL;

BRAIN STEM; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DECREASED APPETITE; DRUG HALF LIFE; DRUG TARGETING; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; FOREBRAIN; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOTENSION; HYPOTHALAMUS; KNOCKOUT MOUSE; LIBIDO DISORDER; MONOTHERAPY; NAUSEA; NERVOUS SYSTEM; NONHUMAN; PENILE BLOOD VESSEL; PENIS ERECTION; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SPINAL CORD; STRETCHING; SYNCOPE; YAWNING;

EID: 34447269241     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026610707011111     Document Type: Review

References (60)

1. Wikberg, J.E., et al., New aspects on the melanocortins and their receptors. Pharmacol. Res., 2000, 42(5): p. 393-420.
2. Vergoni, A.V., et al., Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats. Eur. J. Pharmacol., 1998, 362: p. 95-101.
3. Fan, W., et al., Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature, 1997, 385: p. 165-168.
4. van der Kraan, M., et al., Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology, 1998, 139: p. 2348-2355.
5. Schioth, H.B. and H. Watanobe, Melanocortins and reproduction. Brain Res. Brain Res. Rev., 2002, 38(3): p. 340-50.
6. Ferrari, W., G.L. Gessa, and L. Vargiu, Behavioral effects induced by intracisternally injected ACTH and MSH. Ann. N. Y. Acad. Sci., 1963, 104: p. 330-45.
7. Hadley, M.E., Discovery that a melanocortin regulates sexual functions in male and female humans. Peptides, 2005, 26(10): p. 1687-9.
8. Meisel, R. and B. Sachs, Chapter 35: The Physiology of Male Sexual Behavior, in The Physiology of Reproduction, 2nd Ed., K. E and N. JD, Editors. 1994, Raven Press Ltd.: New York. p. 3-105.
9. Giuliano, F. and O. Rampin, Neural control of erection. Physiol. Behav., 2004, 83(2): p. 189-201.
10. Hart, B.L., Testosterone regulation of sexual reflexes in spinal male rats. Science, 1967, 155(767): p. 1283-4.
11. Burnett, A.L., et al., Nitric oxide: a physiologic mediator of penile erection. Science, 1992, 257(5068): p. 401-3.
12. Kim, N., et al., A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J. Clin. Invest., 1991, 88(1): p. 112-8.
13. Ignarro, L.J., et al., Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem. Biophys. Res. Commun., 1990, 170(2): p. 843-50.
14. Giuliano, F., Control of penile erection by the melanocortinergic system: experimental evidences and therapeutic perspectives. J. Androl., 2004, 25(5): p. 683-91.
15. Koyanagi, T., N. Horimoto, and H. Nakano, REM sleep determined using in utero penile tumescence in the human fetus at term. Biol. Neonate., 1991, 60 Suppl 1: p. 30-5.
16. Monaghan, E.P., J. Arjomand, and S.M. Breedlove, Brain lesions affect penile reflexes. Horm. Behav., 1993, 27(1): p. 122-31.
17. Liu, Y.C., J.D. Salamone, and B.D. Sachs, Impaired sexual response after lesions of the paraventricular nucleus of the hypothalamus in male rats. Behav. Neurosci., 1997, 111(6): p. 1361-7.
18. Marson, L., M.S. List, and K.E. McKenna, Lesions of the nucleus paragigantocellularis alter ex copula penile reflexes. Brain Res., 1992, 592(1-2): p. 187-92.
19. Liu, Y.C. and B.D. Sachs, Erectile function in male rats after lesions in the lateral paragigantocellular nucleus. Neurosci. Lett., 1999, 262(3): p. 203-6.
20. Kondo, Y., B.D. Sachs, and Y. Sakuma, Importance of the medial amygdala in rat penile erection evoked by remote stimuli from estrous females. Behav. Brain Res., 1998, 91(1-2): p. 215-22.
21. Hughes, A.M., B.J. Everitt, and J. Herbert, The effects of simultaneous or separate infusions of some pro-opiomelanocortin-derived peptides (beta-endorphin, melanocyte stimulating hormone, and corticotrophin-like intermediate polypeptide) and their acetylated derivatives upon sexual and ingestive behaviour of male rats. Neuroscience, 1988, 27(2): p. 689-698.
22. Wessells, H., J.E. Blevins, and T.W. Vanderah, Melanocortinergic control of penile erection. Peptides, 2005, 26(10): p. 1972-7.
23. Caquineau, C., et al., Effects of alpha-melanocyte-stimulating hormone on magnocellular oxytocin neurones and their activation at intromission in male rats. J. Neuroendocrinol., 2006, 18(9): p. 685-91.
24. Jacobowitz, D.M. and T.L. O'Donohue, alpha-Melanocyte stimulating hormone: immunohistochemical identification and mapping in neurons of rat brain. Proc. Natl. Acad. Sci. USA, 1978, 75(12): p. 6300-4.
25. Joseph, S.A., W.H. Pilcher, and C. Bennett-Clarke, Immunocytochemical localization of ACTH perikarya in nucleus tractus solitarius: evidence for a second opiocortin neuronal system. Neurosci. Lett., 1993, 38(3): p. 221-5.
26. Williams, D.L., et al., Brainstem melanocortin 3/4 receptor stimulation increases uncoupling protein gene expression in brown fat. Endocrinology, 2003, 144(11): p. 4692-7.
27. Giuliano, F., et al., Spinal proerectile effect of oxytocin in anesthetized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2001, 280(6): p. R1870-7.
28. Veronneau-Longueville, F., et al., Oxytocinergic innervation of autonomic nuclei controlling penile erection in the rat. Neuroscience, 1999, 93(4): p. 1437-47.
29. van der Kraan, M., et al., Expression of melanocortin receptors and pro-opiomelanocortin in the rat spinal cord in relation to neurotrophic effects of melanocortins. Brain Res. Mol. Brain Res., 1999, 63(2): p. 276-86.
30. Van der Ploeg, L.H., et al., A role for the melanocortin 4 receptor in erectile function. Proc. Natl. Acad. Sci. USA, 2002, 99(17): p. 11381-11386.
31. Wessells, H., et al., Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2 induces penile erection via brain and spinal melanocortin receptors. Neuroscience, 2003, 118(3): p. 755-62.
32. Mizusawa, H., P. Hedlund, and K.E. Andersson, alpha-Melanocyte stimulating hormone and oxytocin induced penile erections, and intracavernous pressure increases in the rat. J. Urol., 2002, 167(2 Pt 1): p. 757-60.
33. Giuliano, F., et al., Melanotan-II: Investigation of the inducer and facilitator effects on penile erection in anaesthetized rat. Neuroscience, 2006, 138(1): p. 293-301.
34. Vemulapalli, R.K., S.; Salisbury, B.; Parker, E.; Davis, H., Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NO. Br. J. Pharmacol., 2001, 134: p. 1705-1710.
35. Grieco, P., et al., Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors. J. Med. Chem., 2002, 45(24): p. 5287-94.
36. Haskell-Luevano, C., et al., Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6,7,8, and 9 positions. Peptides, 2000, 21: p. 49-57.
37. Bertolini, A., et al., Induction of sexual excitement with intraventricular ACTH; permissive role of testosterone in the male rabbit. Life Sci., 1968, 7: p. 1203-1206.
38. Al-Obeidi, F., et al., Potent and prolonged acting cyclic lactam analogues of α- melanotropin: design based on molecular dynamics. J. Med. Chem., 1989, 32: p. 2555-2561.
39. Dorr, R.T., et al., Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci., 1996, 58(20): p. 1777-1784.
40. Wessells, H., et al., Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J. Urol., 1998, 160(2): p. 389-93.
41. Wessells, H., et al., Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology, 2000, 56(4): p. 641-6.
42. Molinoff, P.B., et al., PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann. N. Y. Acad. Sci., 2003, 994: p. 96-102.
43. Rosen, R.C., et al., Evaluation of the safety, pharmacokinetics and phatmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra. Int. J. Impot. Res., 2004, 16(2): p. 135-42.
44. Diamond, L.E., et al., Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. Int. J. Impot. Res., 2004, 16(1): p. 51-9.
45. Wessells, H., H. Padma-Nathan, J. Raifer, Feldman, R., Rosen, R., Molinoff, P., Diamond, L., Earle, D., and Powers B., At-home efficacy of an intranasally administered melanocortin receptor agonist, PT-141, in men with erectile dysfunction (ED), in American Urology Association Annual Meeting. 2004: San Francisco, California.
46. Diamond, L.E., et al., Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response. Urology, 2005, 65(4): p. 755-9.
47. Palatin Technologies, company communications.
48. Martin, W.J., et al., Activation of melanocortin MC(4) receptors increases erectile activity in rats ex copula. Eur. J. Pharmacol., 2002, 454(1): p. 71-9.
49. Martin, W.J. and D.E. MacIntyre, Melanocortin receptors and erectile function. Eur. Urol., 2004, 45(6): p. 706-13.
50. Sebhat, I.K., et al., Design and pharmacology of N-[(3R)-1,2,3,4-tetrahy-droisoquinolinium-3-ylcarbonyl]-(1R)-1- (4-chlorobenzyl)-2-[4-cyclo-hexyl-4-(1H-1,2,4-triazol- 1-ylmethyl) piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. J. Med. Chem., 2002, 45 (21): p. 4589-93.
51. Arora, S. and Anubhuti, Role of neuropeptides in appetite regulation and obesity - A review. Neuropeptides, 2006.
52. Schioth, H.B., et al., Selectivity of cyclic [D-Na17] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes. Peptides, 1997, 18(7): p. 1009-13.
53. Schioth, H.B., R. Muceniece, and J.E. Wikberg, Characterization of the binding of MSH-B, HB-228, GHRP-6 and 153N-6 to the human melanocortin receptor subtypes. Neuropeptides, 1997, 31(6): p. 565-71.
54. Argiolas, A., et al., ACTH- and alpha-MSH- induced grooming, stretching, yawning and penile erection in male rats: Site of action in the brain and role of melanocortin receptors. Brain Res. Bull., 2000, 51(5): p. 425-431.
55. Bednarek, M.A., et al., Selective, high affinity peptide antagonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro. J. Med. Chem., 2001, 44(22): p. 3665-72.
56. Bagnol, D., et al., Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J. Neurosci., 1999, 19(18): p. RC26.
57. Mayorov, A.V., et al., Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMCSR antagonist activities. J. Med. Chem., 2006, 49(6): p. 1946-52.
58. Grieco, P., et al., D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity. J. Med. Chem., 2000, 43(26): p. 4998-5002.
59. Ye, Z., et al., Discovery and activity of (1R,4S,6R)-N-[(1R)-2-[4-cyclohexyl-4- (1,1-dimethylethyl)amino]carbonyl]- 1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-2-methyl-2- azabicycl o[2.2.2]octane-6-carboxamide (3, RY764), a potent and selective melanocortin subtype-4 receptor agonist. Bioorg. Med. Chem. Lett., 2005, 15(15): p. 3501-5.
60. Tota, M.R., et al., Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors. Biochemistry, 1999, 38(3): p. 897-904.